Product Name SARS-CoV-2/ Influenza A&B Antigen Rapid Test Used For 2019 novel coronavirus Antigen test Specimen Nasopharyngeal Swab Packing 25 tests/box, 1 test/box Storage temperature Storage temperature 2~30℃ Detection Time 10 minutes Diverse cooperation modes OEM/ODM Specification Package 25 Tests/box 800 Tests/CTN CTN Size: 61*41*40cm N.W./G.W.: 12.2/13.2KGS
Product Name COVID-19 Antigen Rapid Test(Latex) Used For 2019 novel coronavirus Antigen test Specimen Oropharyngeal saliva/sputum/stool Packing 25 tests/box, 1 test/box Storage temperature 2~30℃ Detection Time 10-15 minutes Diverse cooperation modes OEM/ODM ● The novel coronaviruses belong to the β genus. COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavir...
Product Name COVID-19 Antigen Rapid Test (Colloidal Gold) Used For 2019 novel coronavirus Antigen test Specimen Nasopharyngeal Swab Packing 25 tests/box, 1 test/box Storage temperature Storage temperature 2~30℃ Detection Time 10-15 minutes Diverse cooperation modes OEM/ODM ● The novel coronaviruses belong to the β genus. COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the n...
Product Name COVID-19 Antigen Rapid Test (Colloidal Gold) Used For 2019 novel coronavirus Antigen test Specimen Anterior Nasal Swab Packing 25 tests/box, 1 test/box Storage temperature Storage temperature 2~30℃ Detection Time 10-15 minutes Diverse cooperation modes OEM/ODM ● The novel coronaviruses belong to the β genus. COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the n...
Founded in December 2010, with a total investment of 43 million USD, a total construction area of 45929 square meters and aregistered capital of 12 million USD, Joinstar Biomedical Technology Co., Ltd. is a biomedical technology enterprise focusing on medical in vitro diagnostic products…
In 2012, JOINSTAR obtained the application patent authorization of Heparin Binding Protein, becoming the exclusive Chinese enterprise to obtain the PATENT authorization of HBP. HBP was also introduced from Lund University in Sweden, Axis-Shield Diagnostics Ltd. The picture shows Dr. Adam Linde The president of the European sepsis alliance, Prof. Evangelos J. Giamarellos-Bourboulis, found that HBP > 18 ng/mL and il-6 > 30pg/mL at admission for sepsis caused by COVID-19 were independent risk factors for severe respiratory failure (SRF). HBP > 35 ng/mL and il-6 > 30pg/mL at admis...
01 . COVID-19 Antigen Schnelltest (Colloidal Gold) developed by Joinstar Biomedical Technology have obtained the performance verification from Paul Ehrlich institute. Together with Abbott, Roche, SD, BD, Siemens LumiraDX, and other internationally renowned companies, Joinstar Biomedical Technology became one of the few antigen manufacturers approved by PEI in the first batch globally. “Paul-ehrlich-institut” (PEI) represents the German federal institute of vaccines and Biomedicine, responsible for medic...